| Drug Name | Active Ingredient | Dosage Form | Strength | Manufacturers | Manufacturers | Approval No. | Same Variety(Same Strength) | Approval Date | Drug Classification | Details |
|---|---|---|---|---|---|---|---|---|---|---|
| 硫酸依替米星注射液 | etimicin sulfate | Injection | 1ml:50mg (按C21H43N5O7计) | 常州方圆制药有限公司 | Changzhou Fangyuan Pharmaceutical Co Ltd | 国药准字H20020129 | view | 2020-08-21 | Medicare(class B) | view |
| 硫酸依替米星注射液 | etimicin sulfate | Injection | 2ml:100mg (按C21H43N5O7计) | 常州方圆制药有限公司 | Changzhou Fangyuan Pharmaceutical Co Ltd | 国药准字H20020128 | view | 2020-08-21 | Medicare(class B) | view |
| 硫酸依替米星注射液 | etimicin sulfate | Injection | 4ml:200mg (按C21H43N5O7计) | 常州方圆制药有限公司 | Changzhou Fangyuan Pharmaceutical Co Ltd | 国药准字H20055122 | view | 2020-08-21 | Medicare(class B) | view |
| 硫酸依替米星注射液 | etimicin sulfate | Injection | 2ml:100mg(按C21H43N5O7计算) | 无锡济煜山禾药业股份有限公司 | Wuxi Jiyu Shanhe Pharmaceutical Co Ltd | 国药准字H19991422 | view | 2020-08-13 | Medicare(class B) | view |
| 硫酸依替米星注射液 | etimicin sulfate | Injection | 1ml:50mg(按C21H43N5O7计算) | 无锡济煜山禾药业股份有限公司 | Wuxi Jiyu Shanhe Pharmaceutical Co Ltd | 国药准字H19991423 | view | 2020-08-13 | Medicare(class B) | view |
| 硫酸依替米星注射液 | etimicin sulfate | Injection | 4ml:200mg(按C21H43N5O7计) | 无锡济煜山禾药业股份有限公司 | Nanjing Hencer Pharmaceutical Co Ltd | 国药准字H20031235 | view | 2020-08-13 | Medicare(class B) | view |